Sagimet Biosciences Inc.
SGMT
$2.21
$0.199.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -45.57M | -37.52M | -29.25M | -27.92M | -27.88M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.18M | 4.01M | 4.84M | 4.92M | 5.09M |
| Change in Net Operating Assets | -1.05M | -4.99M | 1.60M | 106.00K | -978.00K |
| Cash from Operations | -42.44M | -38.49M | -22.80M | -22.89M | -23.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.68M | -91.15M | -91.78M | -3.82M | 12.58M |
| Cash from Investing | -61.68M | -91.15M | -91.78M | -3.82M | 12.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 105.86M | 109.38M | 195.55M | 195.55M | 89.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.05M | -4.56M | -3.52M | -4.40M | -3.52M |
| Cash from Financing | 104.82M | 104.82M | 192.03M | 191.15M | 86.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 701.00K | -24.83M | 77.45M | 164.44M | 74.98M |